Browse the corpus

For decades, the CD4 cell count measurement has been used to understand the progression of HIV infection. HIV is a fatal infection that targets and destroys CD4 T lymphocytes in the peripheral blood. CD4 T lymphocytes are a part of human T-lymphocyte cells produced in the bone marrow and eventually mature in the thymus. These cells play a critical role in the immune system by circulating throughout the body to fight against bacteria, viruses, and other organisms. If HIV goes untreated, the virus enters the cell and replicates, which eventually causes CD4 cells to die. The remaining infected cells release virions, which infect other cells, leading to the progression of the disease. The loss of CD4 T lymphocytes results in the inability to have a proper immune response.[1][2] CD4 cell count is a laboratory test that measures the number of CD4 T cells. The normal range is between 500 to 1500 cells/mm3. Clinicians use this test to monitor the destruction of CD4 cells, and it also monitors the effectiveness of antiretroviral therapy. The CD4 cell count is now the most reliable indicator of disease progression and is used to stage disease and guide medical therapy.[3][4] According to the Centers for Disease Control and Prevention, a key indication for diagnosing AIDS is when the CD4 cell count drops below 200 cells/mm3. The decline of CD4 T cells can lead to opportunistic infections and increase mortality.[5]

The CD4 count is a critical laboratory parameter for assessing immunosuppressed patients, especially those with HIV. Nurse practitioners, primary care physicians, and other healthcare providers should be familiar with the normal range of CD4 counts, typically between 500 to 1500 cells/mm³, to recognize deviations indicative of immunosuppression. CD4 testing is recommended for all patients at the time of HIV diagnosis to establish a baseline and assess the degree of immune dysfunction. According to the Public Health Service, HIV-positive patients should undergo regular CD4 monitoring every 3 to 6 months to track disease progression and evaluate the risk of opportunistic infections. CD4 counts below 200 cells/mm³ are a defining criterion for an AIDS diagnosis and indicate a significantly elevated risk for life-threatening infections and malignancies. Beyond its diagnostic value, the CD4 count is also a marker of treatment success or failure.